Elekta AB 

$5.53
67
-$0.03-0.54% Monday 17:40

Statistics

Day High
5.49
Day Low
5.46
52W High
6.93
52W Low
4.35
Volume
100
Avg. Volume
-
Mkt Cap
2.04B
P/E Ratio
-
Dividend Yield
4.68%
Dividend
0.26

Upcoming

Dividends

4.68%Dividend Yield
Mar 26
$0.13
Sep 25
$0.13
Mar 25
$0.12
Sep 24
$0.12
Mar 24
$0.12
10Y Growth
24.27%
5Y Growth
19.36%
3Y Growth
5.06%
1Y Growth
5.74%

Earnings

27AugExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Next
0.03
0.07
0.11
0.16
Expected EPS
0.0506249568
Actual EPS
N/A

Financials

1.31%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
3.69BRevenue
48.34MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EKTAY. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap102.97B
Medtronic competes with Elekta in the neurosurgical market, offering products for brain surgeries and pain management that overlap with Elekta's Gamma Knife radiosurgery systems.
Intuitive Surgical
ISRG
Mkt Cap145.58B
Intuitive Surgical competes in the surgical space with robotic systems that, while not directly radiation therapy, offer alternative treatments for conditions Elekta's products also address.
Boston Scientific
BSX
Mkt Cap69.72B
Boston Scientific competes in the medical device market, particularly in neuromodulation, where its products can be seen as alternatives to Elekta's for certain conditions.
Smith & Nephew
SNN
Mkt Cap12.95B
Smith & Nephew competes in the advanced wound management and surgical devices market, indirectly competing with Elekta's offerings in surgical and oncology care.
Zimmer Biomet
ZBH
Mkt Cap17.13B
Zimmer Biomet competes in the musculoskeletal healthcare market, including surgical solutions that can indirectly compete with Elekta's products for certain therapeutic and diagnostic applications.
Stryker
SYK
Mkt Cap119.69B
Stryker competes across several medical device markets, including neurotechnology and spine, where its products can compete with Elekta's neurosurgical and radiosurgery offerings.
Globus Medical
GMED
Mkt Cap10.91B
Globus Medical competes in the spine and neurosurgery markets with products that can be alternatives to Elekta's solutions for spinal and brain conditions.
Abbvie
ABBV
Mkt Cap402.35B
AbbVie, through its acquisition of Allergan, competes in the neuroscience space, offering pharmaceutical alternatives to Elekta's device-based treatments for neurological conditions.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson, through its medical devices division, competes in several areas including surgery and oncology, offering products that can be seen as alternatives to Elekta's radiation therapy and neurosurgery devices.

About

Elekta AB (publ) is a global medical technology company dedicated to developing and delivering advanced clinical solutions for the treatment of cancer and brain disorders. Its comprehensive portfolio includes innovative radiotherapy systems such as the Elekta Unity MR-Linac, the Elekta Harmony linear accelerator, Elekta Infinity for diverse patient radiotherapy requirements, and the Elekta Synergy digital accelerator for advanced image-guided radiation therapy. Specific solutions like Versa HD are available for managing brain metastases. The company also supplies crucial treatment management software, automated and integrated quality assurance tools, and hardware and software for motion management. Further augmenting its oncology offerings, Elekta provides MOSAIQ Plaza for integrated multidisciplinary cancer care and Elekta Axis Cloud for managed hosting. Within brachytherapy, key products include the image-guided Elekta Studio, the mobile ImagingRing CT scanner, Oncentra Brachy for streamlining repetitive tasks, the Elekta Flexitron afterloader for precise workflow execution, and specialized applicators like Venezia and Geneva for cervical cancer treatment. For neurological conditions, Elekta offers a suite of advanced radiosurgery and neurosurgery solutions. This includes the Leksell Gamma Knife series – Icon for personalized radiation treatment, Perfexion for neurosurgical applications, and Lightning for accelerated procedures. Its neurosurgery product line features the Leksell Vantage Stereotactic System for intracranial interventions and the Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. Founded in 1972, Elekta maintains its corporate headquarters in Stockholm, Sweden.
Show more...
CEO
Dr. Laurent Leksell
Employees
4541
Country
United States
ISIN
US28617Y1010

Listings

0 Comments

Share your thoughts

FAQ

What is Elekta AB stock price today?
The current price of EKTAY is $5.53 USD — it has decreased by -0.54% in the past 24 hours. Watch Elekta AB stock price performance more closely on the chart.
What is Elekta AB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Elekta AB stocks are traded under the ticker EKTAY.
Is Elekta AB stock price growing?
EKTAY stock has fallen by -1.43% compared to the previous week, the month change is a -5.15% fall, over the last year Elekta AB has showed a +10.2% increase.
What is Elekta AB market cap?
Today Elekta AB has the market capitalization of 2.04B
When is the next Elekta AB earnings date?
Elekta AB is going to release the next earnings report on August 27, 2026.
What were Elekta AB earnings last quarter?
EKTAY earnings for the last quarter are 0.06 USD per share, whereas the estimation was 0.16 USD resulting in a -60.43% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Elekta AB revenue for the last year?
Elekta AB revenue for the last year amounts to 3.69B USD.
What is Elekta AB net income for the last year?
EKTAY net income for the last year is 48.34M USD.
Does Elekta AB pay dividends?
Yes, EKTAY dividends are paid semi-annual. The last dividend per share was 0.13 USD. As of today, Dividend Yield (FWD)% is 4.68%.
How many employees does Elekta AB have?
As of June 16, 2026, the company has 4,541 employees.
In which sector is Elekta AB located?
Elekta AB operates in the Health & Wellness sector.
When did Elekta AB complete a stock split?
The last stock split for Elekta AB was on September 25, 2012 with a ratio of 4:1.
Where is Elekta AB headquartered?
Elekta AB is headquartered in Stockholm, United States.